Cas:920966-16-1 tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate manufacturer & supplier

Chemical Name:tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate

CAS.NO:920966-16-1

Synonyms:tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate

Molecular Formula:C₁₂H₂₃NO₃

Molecular Weight:229.31600

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:58.56000

Exact Mass:229.16800

LogP:2.45310

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate Use and application,tert-Butyl cis-(3-hydroxymethyl)-cyclohexylcarbamate technical grade,usp/ep/jp grade.

Related News: “We’re going to further invest in research and development to continue to build our pipeline of products, in a more sophisticated way,” he says, holding up a pocket-sized wearable device and a tiny insulin pen to his screen’s camera. “We really believe in this business for the next—we hope—70 years.” 4-butyl-2-methoxy-1-nitronaphthalene manufacturers The $672 million raised in the listing will go toward expanding Stevanato’s factories in Italy and China and building a new plant for vials, syringes and cartridges in Fishers, Indiana—sweetened by $2.9 million in conditional tax credits from the state—that’s expected to bring more than 200 jobs to the area. (4S,9S)-2-hydroperoxy-13,24,44,94-pentaoxolo[5,4]hexaoxane-4,9-diol suppliers “We’re going to further invest in research and development to continue to build our pipeline of products, in a more sophisticated way,” he says, holding up a pocket-sized wearable device and a tiny insulin pen to his screen’s camera. “We really believe in this business for the next—we hope—70 years.” (3S)-4-{[4-(2-Butynyloxy)phenyl]sulfonyl}-N-hydroxy-2,2-dimethyl-3-thiomorpholine carboxamide 1,1-dioxide vendor & factory CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. ,Along with Natural Biogenix were Symbiotec Pharmalab, Macleods Pharmaceutical, Optimus Drugs, Sudarshan Pharma, Saraca Laboratories, Emmennar Pharma, Hindys Lab, Aarti Speciality, Meghmani LLP and and Sadhana Nitro Chem.